Citation Impact
Citing Papers
HLA Class I-Restricted T-Cell Responses May Contribute to the Control of Human Immunodeficiency Virus Infection, but Such Responses Are Not Always Necessary for Long-Term Virus Control
2008
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
Immune loss as a driver of coexistence during host-phage coevolution
2018
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Complete Replication of Hepatitis C Virus in Cell Culture
2005 StandoutScienceNobel
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
A drug-controllable tag for visualizing newly synthesized proteins in cells and whole animals
2008 StandoutNobel
Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4 + and CD8 + T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection
2001
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Investigating Signs of Recent Evolution in the Pool of Proviral HIV Type 1 DNA during Years of Successful HAART
2007
Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism
2009 StandoutNobel
Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA
2003
HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir
2005
Tolerance and exhaustion: defining mechanisms of T cell dysfunction
2013
MicroRNAs
2004 Standout
R5 to X4 Switch of the Predominant HIV-1 Population in Cellular Reservoirs During Effective Highly Active Antiretroviral Therapy
2005
HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges
2006
Mechanisms of Protection Induced by Attenuated Simian Immunodeficiency Virus
2002
Dynamics of Total, Linear Nonintegrated, and Integrated HIV‐1 DNA In Vivo and In Vitro
2008
Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy
1999
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
2013 Standout
Antibodies, viruses and vaccines
2002
Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know
2004
Ecology of prokaryotic viruses
2003 Standout
Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef
1999
How sisters grow apart: mycobacterial growth and division
2014
Effect of Treatment, during Primary Infection, on Establishment and Clearance of Cellular Reservoirs of HIV-1
2005
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
2002 Nature
T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion
2013
Antibody neutralization and escape by HIV-1
2003 StandoutNature
Overcoming T cell exhaustion in infection and cancer
2015
Strategies for designing and optimizing new generation vaccines
2001
RNA-guided genetic silencing systems in bacteria and archaea
2012 StandoutNatureNobel
Illumination of growth, division and secretion by metabolic labeling of the bacterial cell surface
2015 StandoutNobel
Immune Memory and Exhaustion: Clinically Relevant Lessons from the LCMV Model
2015
Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infection
2002
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
Bacteria–phage coevolution as a driver of ecological and evolutionary processes in microbial communities
2014
Hepatitis C Virus Core Protein Acts as a trans-Modulating Factor on Internal Translation Initiation of the Viral RNA
2005
Heterogeneity of intracellular replication of bacterial pathogens
2013
Immunopathogenesis and immunotherapy in AIDS virus infections
2003
Presentation of SIVgag to monkey T cells using dendritic cells transfected with a recombinant adenovirus
2000 StandoutNobel
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Revealing the world of RNA interference
2004 StandoutNatureNobel
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
2006 Standout
Progress and obstacles in the development of an AIDS vaccine
2006
Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus Vector
2006
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
2009 Standout
The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines
2004
The Biology of CRISPR-Cas: Backward and Forward
2018 StandoutNobel
Modelling viral and immune system dynamics
2002
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection
2001
Molecular and cellular insights into T cell exhaustion
2015 Standout
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
2003 Standout
Novel Insights into Hepatitis C Virus Replication and Persistence
2004
Equivalent Immunogenicity of the Highly Attenuated Poxvirus-Based ALVAC-SIV and NYVAC-SIV Vaccine Candidates in SIVmac251-Infected Macaques
2002
A Single-Cell Perspective on Non-Growing but Metabolically Active (NGMA) Bacteria
2013
Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees
2004 StandoutNobel
Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034
2006
Genotypic Analysis of HIV‐1 Drug Resistance at the Limit of Detection: Virus Production without Evolution in Treated Adults with Undetectable HIV Loads
2004
Hepatitis C Virus Core Protein Is a Potent Inhibitor of RNA Silencing-Based Antiviral Response
2006
CD8+ Lymphocytes Control Viral Replication in SIVmac239-Infected Rhesus Macaques without Decreasing the Lifespan of Productively Infected Cells
2010
Replication of hepatitis C virus
2007 StandoutNobel
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Magnitude of Functional CD8+T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in Plasma
2002
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load
2003
Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus
2004 StandoutNobel
Persistence of Wild-Type Virus and Lack of Temporal Structure in the Latent Reservoir for Human Immunodeficiency Virus Type 1 in Pediatric Patients with Extensive Antiretroviral Exposure
2002
Replication of hepatitis C virus
2000
Viral and Latent Reservoir Persistence in HIV-1–Infected Patients on Therapy
2006
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Tuberculosis Pathogenesis and Immunity
2011
Potentiation of Simian Immunodeficiency Virus (SIV)-Specific CD4+ and CD8+ T Cell Responses by a DNA-SIV and NYVAC-SIV Prime/Boost Regimen
2001
Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment
2003
Epitope Escape Mutation and Decay of Human Immunodeficiency Virus Type 1-Specific CTL Responses
2003
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity
2001
Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen
2000
Early Regeneration of Thymic Progenitors in Rhesus Macaques Infected with Simian Immunodeficiency Virus
1998
Visualization of mycobacterial membrane dynamics in live cells
2017 StandoutNobel
Effects of in Vivo Cd8+ T Cell Depletion on Virus Replication in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine
1999
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
High Levels of Viral Replication during Primary Simian Immunodeficiency Virus SIVagm Infection Are Rapidly and Strongly Controlled in African Green Monkeys
2000 StandoutNobel
The Differential Ability of HLA B*5701+Long-Term Nonprogressors and Progressors To Restrict Human Immunodeficiency Virus Replication Is Not Caused by Loss of Recognition of Autologous ViralgagSequences
2003
In Vitro and In Vivo Efficacy of β-Lactams against Replicating and Slowly Growing/Nonreplicating Mycobacterium tuberculosis
2013
Naive T-Cell Depletion Related to Infection by X4 Human Immunodeficiency Virus Type 1 in Poor Immunological Responders to Highly Active Antiretroviral Therapy
2006 StandoutNobel
Resistance to Replication of Human Immunodeficiency Virus Challenge in SCID-Hu Mice Engrafted with Peripheral Blood Mononuclear Cells of Nonprogressors Is Mediated by CD8+T Cells and Associated with a Proliferative Response to p24 Antigen
2000
Osmosensory signaling in Mycobacterium tuberculosis mediated by a eukaryotic-like Ser/Thr protein kinase
2013 StandoutNobel
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
2003
Emerging Infectious Diseases of Wildlife-- Threats to Biodiversity and Human Health
2000 StandoutScience
Human Immunodeficiency Virus Type 1 Escape from RNA Interference
2003
Estimating the Rate of Intersubtype Recombination in Early HIV-1 Group M Strains
2012
A Novel Antiviral Intervention Results in More Accurate Assessment of Human Immunodeficiency Virus Type 1 Replication Dynamics and T-Cell Decay In Vivo
2003
Maintenance of viral suppression in HIV-1–infected HLA-B*57+ elite suppressors despite CTL escape mutations
2006
Loss of HIV-1–specific CD8+ T Cell Proliferation after Acute HIV-1 Infection and Restoration by Vaccine-induced HIV-1–specific CD4+ T Cells
2004
Maintenance of Large Numbers of Virus-Specific CD8+ T Cells in HIV-Infected Progressors and Long-Term Nonprogressors
2000
Globalization, International Law, and Emerging Infectious Diseases
1996
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
Detection of HIV Vaccine-Induced Cell-Mediated Immunity in HIV-Seronegative Clinical Trial Participants Using an Optimized and Validated Enzyme-Linked Immunospot Assay
2007
Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy
2000
Mathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 Cells
2006 StandoutNobel
Limits on Replenishment of the Resting CD4+ T Cell Reservoir for HIV in Patients on HAART
2007
Presence of HIV-1 Gag-Specific IFN-γ+IL-2+ and CD28+IL-2+ CD4 T Cell Responses Is Associated with Nonprogression in HIV-1 Infection
2002
Mature Dendritic Cells Infected with Canarypox Virus Elicit Strong Anti-Human Immunodeficiency Virus CD8+and CD4+T-Cell Responses from Chronically Infected Individuals
2001 StandoutNobel
HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8+ T Cell Response against HIV-1
2006
Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infection
2002
Containment of Simian Immunodeficiency Virus Infection in Vaccinated Macaques: Correlation with the Magnitude of Virus-Specific Pre- and Postchallenge CD4+ and CD8+ T Cell Responses
2002
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Hierarchical Targeting of Subtype C Human Immunodeficiency Virus Type 1 Proteins by CD8+T Cells: Correlation with Viral Load
2004
HIV VACCINES
2005
The impact of training informal health care providers in India: A randomized controlled trial
2016 StandoutScienceNobel
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Heterologous Human Immunodeficiency Virus Type 1 Priming-Boosting Immunization Strategies Involving Replication-Defective Adenovirus and Poxvirus Vaccine Vectors
2004
Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses
2007
Dendritic Cells, Infected with Vesicular Stomatitis Virus-Pseudotyped HIV-1, Present Viral Antigens to CD4+ and CD8+ T Cells from HIV-1-Infected Individuals
2000 StandoutNobel
Analysis of Human Immunodeficiency Virus Type 1 Gene Expression in Latently Infected Resting CD4 + T Lymphocytes In Vivo
2003
Spatial Vulnerability: Bacterial Arrangements, Microcolonies, and Biofilms as Responses to Low Rather than High Phage Densities
2012
Intrahepatic Hepatitis C Virus Replication Correlates with Chronic Hepatitis C Disease Severity In Vivo
2006
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Health Care Competition and Antibiotic Use in T aiwan
2015
Prospects for the Future
2002 StandoutScienceNobel
De novo design of protein logic gates
2020 StandoutScienceNobel
Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication
2004 StandoutNobel
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Works of John E. Mittler being referenced
Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen
1998
T-Cell Homeostasis, Competition, and Drift: AIDS as HIV-Accelerated Senescence of the Immune Repertoire
1996
A replication clock for Mycobacterium tuberculosis
2009
Population dynamics of HIV pathogenesis
1995
The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy
2000
Effect of Drug Efficacy and the Eclipse Phase of the Viral Life Cycle on Estimates of HIV Viral Dynamic Parameters
2001
Influence of delayed viral production on viral dynamics in HIV-1 infected patients
1998
Dynamics of Hepatitis C Virus Replication in Human Liver
2003
The Population Genetics of Antibiotic Resistance II: Analytic Theory for Sustained Populations of Bacteria in a Community of Hosts
1998
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis
1999
Host-Parasite Coexistence: The Role of Spatial Refuges in Stabilizing Bacteria-Phage Interactions
1996
Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques
1999
Short-Term Measures of Relative Efficacy Predict Longer-Term Reductions in Human Immunodeficiency Virus Type 1 RNA Levels following Nelfinavir Monotherapy
2001
Selection for Human Immunodeficiency Virus Type 1 Recombinants in a Patient with Rapid Progression to AIDS
2002
Genotypic Changes in Human Immunodeficiency Virus Type 1 Associated with Loss of Suppression of Plasma Viral RNA Levels in Subjects Treated with Ritonavir (Norvir) Monotherapy
1998